Royce Small-Cap Trust Files 2025 Proxy Statement

TL;DR

Royce Small-Cap Trust filed its DEF 14A proxy statement on 8/18/25. Get ready to vote.

AI Summary

Royce Small-Cap Trust, Inc. filed its definitive proxy statement on August 18, 2025, for its fiscal year ending December 31, 2025. The filing, designated as DEF 14A, outlines information required for its annual shareholder meeting. The company is incorporated in Maryland and its principal executive offices are located at One Madison Avenue, New York, NY.

Why It Matters

This filing provides shareholders with crucial information regarding the company's governance and upcoming decisions, allowing them to make informed voting choices.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) and does not contain new material events or financial disclosures that would typically indicate elevated risk.

Key Numbers

• 2025 — Fiscal Year End (The filing pertains to the company's operations and governance for this fiscal year.)

Key Players & Entities

• ROYCE SMALL-CAP TRUST, INC. (company) — Registrant
• August 18, 2025 (date) — Filing Date
• One Madison Avenue, New York, NY (address) — Business Address
• Maryland (location) — State of Incorporation

FAQ

Filing Documents

• g110578_rvt.htm (DEF 14A) — 404KB
• img001_v1.jpg (GRAPHIC) — 1KB
• img002_v1.jpg (GRAPHIC) — 1KB
• img003_v1.jpg (GRAPHIC) — 1KB
• img004_v1.jpg (GRAPHIC) — 1KB
• img005_v1.jpg (GRAPHIC) — 1KB
• img006_v1.jpg (GRAPHIC) — 37KB
• img007_v1.jpg (GRAPHIC) — 5KB
• img007a_v1.jpg (GRAPHIC) — 2KB
• img008_v1.jpg (GRAPHIC) — 6KB
• img009_v1.jpg (GRAPHIC) — 7KB
• img010_v1.jpg (GRAPHIC) — 1KB
• 0000949377-25-000071.txt ( ) — 494KB

financial statements be included in the Fund’s 2024 Annual Report to Stockholders

financial statements be included in the Fund’s 2024 Annual Report to Stockholders. Nominating Committee The Board has a Nominating Committee (the “Nominating Committee”) composed of the six Independent Directors, namely Ms. Chadwick, Ms. Harper, and Ms. Poston, and Messrs. Grisanti, O’Brien, and Shields. Mr. O’Brien has served as Chair of the Nominating Committee in the past, including during 2023, the last year in which it held meetings. The Board has adopted a Nominating Committee charter for the Fund, a copy of which is included as an exhibit to this Proxy Statement. A copy of the Nominating Committee charter for the Fund may also be obtained by calling 1-800-221-4268 . The Nominating Committee is responsible for identifying and recommending to the Board individuals believed to be qualified to become Board members in the event that a position is vacated or created. The Nominating Committee will consider Director candidates recommended by stockholders. In considering potential nominees, the Nominating Committee will take into consideration (i) the contribution which the person can make to the Board, with consideration given to the person’s business and professional experience, education and such other factors as the Committee may consider relevant, including but not limited to whether a potential nominee’s personal and professional qualities and attributes would provide a beneficial diversity of skills, experience and/or perspective to the Board; (ii) the character and integrity of the person; (iii) whether or not the person is an “interested person” as defined in the Investment Company Act and whether the person is otherwise qualified under applicable laws and regulations to serve as a Director or Independent Director of the Fund; (iv) whether or not the person has any relationships that might impair his or her independence, such as any business, financial or family relationships with Fund management, th

View Full Filing

View this DEF 14A filing on SEC EDGAR